Global Peripheral Arterial Disease (PAD) Therapeutics Market Research Report 2024(Status and Outlook)
Report Overview:
Peripheral artery disease (PAD) is a narrowing of the arteries other than those that supply the heart or the brain. When narrowing occurs in the heart, it is called coronary artery disease, while, in the brain, it is called cerebrovascular disease. Peripheral artery disease most commonly affects the legs, but other arteries may also be involved. The classic symptom is leg pain when walking which resolves with rest, known as intermittent claudication. Other symptoms including skin ulcers, bluish skin, cold skin, or poor nail and hair growth may occur in the affected leg. Complications may include an infection or tissue death which may require amputation; coronary artery disease, or stroke.[3] Up to 50% of cases of PAD are without symptoms.
The Global Peripheral Arterial Disease (PAD) Therapeutics Market Size was estimated at USD 3124.06 million in 2023 and is projected to reach USD 4258.82 million by 2029, exhibiting a CAGR of 5.30% during the forecast period.
This report provides a deep insight into the global Peripheral Arterial Disease (PAD) Therapeutics market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Peripheral Arterial Disease (PAD) Therapeutics Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Peripheral Arterial Disease (PAD) Therapeutics market in any manner.
Global Peripheral Arterial Disease (PAD) Therapeutics Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
AstraZeneca Plc. (UK)
Bayer HealthCare Pharmaceuticals (Germany)
Bristol-Myers Squibb Company (US)
Merck & Co., Inc. (US)
Proteon Therapeutics, Inc. (US)
Sanofi S.A. (France)
Symic Bio, Inc. (US)
TheraVasc Inc. (US)
AnGes MG, Inc. (Japan)
Athersys, Inc. (US)
Betagenon AB (Sweden)
miRagen Therapeutics, Inc. (US)
Multi Gene Vascular Systems Ltd (Israel)
ViroMed Co. Ltd. (Korea)
Market Segmentation (by Type)
Anti-Platelet Drugs
Dual Antiplatelet Therapy Drugs
Others
Market Segmentation (by Application)
Hospitals
Clinics
Others
Geographic Segmentation
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Note: this report may need to undergo a final check or review and this could take about 48 hours.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Peripheral Arterial Disease (PAD) Therapeutics Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
Peripheral artery disease (PAD) is a narrowing of the arteries other than those that supply the heart or the brain. When narrowing occurs in the heart, it is called coronary artery disease, while, in the brain, it is called cerebrovascular disease. Peripheral artery disease most commonly affects the legs, but other arteries may also be involved. The classic symptom is leg pain when walking which resolves with rest, known as intermittent claudication. Other symptoms including skin ulcers, bluish skin, cold skin, or poor nail and hair growth may occur in the affected leg. Complications may include an infection or tissue death which may require amputation; coronary artery disease, or stroke.[3] Up to 50% of cases of PAD are without symptoms.
The Global Peripheral Arterial Disease (PAD) Therapeutics Market Size was estimated at USD 3124.06 million in 2023 and is projected to reach USD 4258.82 million by 2029, exhibiting a CAGR of 5.30% during the forecast period.
This report provides a deep insight into the global Peripheral Arterial Disease (PAD) Therapeutics market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Peripheral Arterial Disease (PAD) Therapeutics Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Peripheral Arterial Disease (PAD) Therapeutics market in any manner.
Global Peripheral Arterial Disease (PAD) Therapeutics Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
AstraZeneca Plc. (UK)
Bayer HealthCare Pharmaceuticals (Germany)
Bristol-Myers Squibb Company (US)
Merck & Co., Inc. (US)
Proteon Therapeutics, Inc. (US)
Sanofi S.A. (France)
Symic Bio, Inc. (US)
TheraVasc Inc. (US)
AnGes MG, Inc. (Japan)
Athersys, Inc. (US)
Betagenon AB (Sweden)
miRagen Therapeutics, Inc. (US)
Multi Gene Vascular Systems Ltd (Israel)
ViroMed Co. Ltd. (Korea)
Market Segmentation (by Type)
Anti-Platelet Drugs
Dual Antiplatelet Therapy Drugs
Others
Market Segmentation (by Application)
Hospitals
Clinics
Others
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Peripheral Arterial Disease (PAD) Therapeutics Market
- Overview of the regional outlook of the Peripheral Arterial Disease (PAD) Therapeutics Market:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Note: this report may need to undergo a final check or review and this could take about 48 hours.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Peripheral Arterial Disease (PAD) Therapeutics Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Peripheral Arterial Disease (PAD) Therapeutics
1.2 Key Market Segments
1.2.1 Peripheral Arterial Disease (PAD) Therapeutics Segment by Type
1.2.2 Peripheral Arterial Disease (PAD) Therapeutics Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 PERIPHERAL ARTERIAL DISEASE (PAD) THERAPEUTICS MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Peripheral Arterial Disease (PAD) Therapeutics Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Peripheral Arterial Disease (PAD) Therapeutics Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 PERIPHERAL ARTERIAL DISEASE (PAD) THERAPEUTICS MARKET COMPETITIVE LANDSCAPE
3.1 Global Peripheral Arterial Disease (PAD) Therapeutics Sales by Manufacturers (2019-2024)
3.2 Global Peripheral Arterial Disease (PAD) Therapeutics Revenue Market Share by Manufacturers (2019-2024)
3.3 Peripheral Arterial Disease (PAD) Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Peripheral Arterial Disease (PAD) Therapeutics Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Peripheral Arterial Disease (PAD) Therapeutics Sales Sites, Area Served, Product Type
3.6 Peripheral Arterial Disease (PAD) Therapeutics Market Competitive Situation and Trends
3.6.1 Peripheral Arterial Disease (PAD) Therapeutics Market Concentration Rate
3.6.2 Global 5 and 10 Largest Peripheral Arterial Disease (PAD) Therapeutics Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 PERIPHERAL ARTERIAL DISEASE (PAD) THERAPEUTICS INDUSTRY CHAIN ANALYSIS
4.1 Peripheral Arterial Disease (PAD) Therapeutics Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF PERIPHERAL ARTERIAL DISEASE (PAD) THERAPEUTICS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 PERIPHERAL ARTERIAL DISEASE (PAD) THERAPEUTICS MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Peripheral Arterial Disease (PAD) Therapeutics Sales Market Share by Type (2019-2024)
6.3 Global Peripheral Arterial Disease (PAD) Therapeutics Market Size Market Share by Type (2019-2024)
6.4 Global Peripheral Arterial Disease (PAD) Therapeutics Price by Type (2019-2024)
7 PERIPHERAL ARTERIAL DISEASE (PAD) THERAPEUTICS MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Peripheral Arterial Disease (PAD) Therapeutics Market Sales by Application (2019-2024)
7.3 Global Peripheral Arterial Disease (PAD) Therapeutics Market Size (M USD) by Application (2019-2024)
7.4 Global Peripheral Arterial Disease (PAD) Therapeutics Sales Growth Rate by Application (2019-2024)
8 PERIPHERAL ARTERIAL DISEASE (PAD) THERAPEUTICS MARKET SEGMENTATION BY REGION
8.1 Global Peripheral Arterial Disease (PAD) Therapeutics Sales by Region
8.1.1 Global Peripheral Arterial Disease (PAD) Therapeutics Sales by Region
8.1.2 Global Peripheral Arterial Disease (PAD) Therapeutics Sales Market Share by Region
8.2 North America
8.2.1 North America Peripheral Arterial Disease (PAD) Therapeutics Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Peripheral Arterial Disease (PAD) Therapeutics Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Peripheral Arterial Disease (PAD) Therapeutics Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Peripheral Arterial Disease (PAD) Therapeutics Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Peripheral Arterial Disease (PAD) Therapeutics Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 AstraZeneca Plc. (UK)
9.1.1 AstraZeneca Plc. (UK) Peripheral Arterial Disease (PAD) Therapeutics Basic Information
9.1.2 AstraZeneca Plc. (UK) Peripheral Arterial Disease (PAD) Therapeutics Product Overview
9.1.3 AstraZeneca Plc. (UK) Peripheral Arterial Disease (PAD) Therapeutics Product Market Performance
9.1.4 AstraZeneca Plc. (UK) Business Overview
9.1.5 AstraZeneca Plc. (UK) Peripheral Arterial Disease (PAD) Therapeutics SWOT Analysis
9.1.6 AstraZeneca Plc. (UK) Recent Developments
9.2 Bayer HealthCare Pharmaceuticals (Germany)
9.2.1 Bayer HealthCare Pharmaceuticals (Germany) Peripheral Arterial Disease (PAD) Therapeutics Basic Information
9.2.2 Bayer HealthCare Pharmaceuticals (Germany) Peripheral Arterial Disease (PAD) Therapeutics Product Overview
9.2.3 Bayer HealthCare Pharmaceuticals (Germany) Peripheral Arterial Disease (PAD) Therapeutics Product Market Performance
9.2.4 Bayer HealthCare Pharmaceuticals (Germany) Business Overview
9.2.5 Bayer HealthCare Pharmaceuticals (Germany) Peripheral Arterial Disease (PAD) Therapeutics SWOT Analysis
9.2.6 Bayer HealthCare Pharmaceuticals (Germany) Recent Developments
9.3 Bristol-Myers Squibb Company (US)
9.3.1 Bristol-Myers Squibb Company (US) Peripheral Arterial Disease (PAD) Therapeutics Basic Information
9.3.2 Bristol-Myers Squibb Company (US) Peripheral Arterial Disease (PAD) Therapeutics Product Overview
9.3.3 Bristol-Myers Squibb Company (US) Peripheral Arterial Disease (PAD) Therapeutics Product Market Performance
9.3.4 Bristol-Myers Squibb Company (US) Peripheral Arterial Disease (PAD) Therapeutics SWOT Analysis
9.3.5 Bristol-Myers Squibb Company (US) Business Overview
9.3.6 Bristol-Myers Squibb Company (US) Recent Developments
9.4 Merck and Co., Inc. (US)
9.4.1 Merck and Co., Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Basic Information
9.4.2 Merck and Co., Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Product Overview
9.4.3 Merck and Co., Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Product Market Performance
9.4.4 Merck and Co., Inc. (US) Business Overview
9.4.5 Merck and Co., Inc. (US) Recent Developments
9.5 Proteon Therapeutics, Inc. (US)
9.5.1 Proteon Therapeutics, Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Basic Information
9.5.2 Proteon Therapeutics, Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Product Overview
9.5.3 Proteon Therapeutics, Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Product Market Performance
9.5.4 Proteon Therapeutics, Inc. (US) Business Overview
9.5.5 Proteon Therapeutics, Inc. (US) Recent Developments
9.6 Sanofi S.A. (France)
9.6.1 Sanofi S.A. (France) Peripheral Arterial Disease (PAD) Therapeutics Basic Information
9.6.2 Sanofi S.A. (France) Peripheral Arterial Disease (PAD) Therapeutics Product Overview
9.6.3 Sanofi S.A. (France) Peripheral Arterial Disease (PAD) Therapeutics Product Market Performance
9.6.4 Sanofi S.A. (France) Business Overview
9.6.5 Sanofi S.A. (France) Recent Developments
9.7 Symic Bio, Inc. (US)
9.7.1 Symic Bio, Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Basic Information
9.7.2 Symic Bio, Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Product Overview
9.7.3 Symic Bio, Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Product Market Performance
9.7.4 Symic Bio, Inc. (US) Business Overview
9.7.5 Symic Bio, Inc. (US) Recent Developments
9.8 TheraVasc Inc. (US)
9.8.1 TheraVasc Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Basic Information
9.8.2 TheraVasc Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Product Overview
9.8.3 TheraVasc Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Product Market Performance
9.8.4 TheraVasc Inc. (US) Business Overview
9.8.5 TheraVasc Inc. (US) Recent Developments
9.9 AnGes MG, Inc. (Japan)
9.9.1 AnGes MG, Inc. (Japan) Peripheral Arterial Disease (PAD) Therapeutics Basic Information
9.9.2 AnGes MG, Inc. (Japan) Peripheral Arterial Disease (PAD) Therapeutics Product Overview
9.9.3 AnGes MG, Inc. (Japan) Peripheral Arterial Disease (PAD) Therapeutics Product Market Performance
9.9.4 AnGes MG, Inc. (Japan) Business Overview
9.9.5 AnGes MG, Inc. (Japan) Recent Developments
9.10 Athersys, Inc. (US)
9.10.1 Athersys, Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Basic Information
9.10.2 Athersys, Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Product Overview
9.10.3 Athersys, Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Product Market Performance
9.10.4 Athersys, Inc. (US) Business Overview
9.10.5 Athersys, Inc. (US) Recent Developments
9.11 Betagenon AB (Sweden)
9.11.1 Betagenon AB (Sweden) Peripheral Arterial Disease (PAD) Therapeutics Basic Information
9.11.2 Betagenon AB (Sweden) Peripheral Arterial Disease (PAD) Therapeutics Product Overview
9.11.3 Betagenon AB (Sweden) Peripheral Arterial Disease (PAD) Therapeutics Product Market Performance
9.11.4 Betagenon AB (Sweden) Business Overview
9.11.5 Betagenon AB (Sweden) Recent Developments
9.12 miRagen Therapeutics, Inc. (US)
9.12.1 miRagen Therapeutics, Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Basic Information
9.12.2 miRagen Therapeutics, Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Product Overview
9.12.3 miRagen Therapeutics, Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Product Market Performance
9.12.4 miRagen Therapeutics, Inc. (US) Business Overview
9.12.5 miRagen Therapeutics, Inc. (US) Recent Developments
9.13 Multi Gene Vascular Systems Ltd (Israel)
9.13.1 Multi Gene Vascular Systems Ltd (Israel) Peripheral Arterial Disease (PAD) Therapeutics Basic Information
9.13.2 Multi Gene Vascular Systems Ltd (Israel) Peripheral Arterial Disease (PAD) Therapeutics Product Overview
9.13.3 Multi Gene Vascular Systems Ltd (Israel) Peripheral Arterial Disease (PAD) Therapeutics Product Market Performance
9.13.4 Multi Gene Vascular Systems Ltd (Israel) Business Overview
9.13.5 Multi Gene Vascular Systems Ltd (Israel) Recent Developments
9.14 ViroMed Co. Ltd. (Korea)
9.14.1 ViroMed Co. Ltd. (Korea) Peripheral Arterial Disease (PAD) Therapeutics Basic Information
9.14.2 ViroMed Co. Ltd. (Korea) Peripheral Arterial Disease (PAD) Therapeutics Product Overview
9.14.3 ViroMed Co. Ltd. (Korea) Peripheral Arterial Disease (PAD) Therapeutics Product Market Performance
9.14.4 ViroMed Co. Ltd. (Korea) Business Overview
9.14.5 ViroMed Co. Ltd. (Korea) Recent Developments
10 PERIPHERAL ARTERIAL DISEASE (PAD) THERAPEUTICS MARKET FORECAST BY REGION
10.1 Global Peripheral Arterial Disease (PAD) Therapeutics Market Size Forecast
10.2 Global Peripheral Arterial Disease (PAD) Therapeutics Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Peripheral Arterial Disease (PAD) Therapeutics Market Size Forecast by Country
10.2.3 Asia Pacific Peripheral Arterial Disease (PAD) Therapeutics Market Size Forecast by Region
10.2.4 South America Peripheral Arterial Disease (PAD) Therapeutics Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Peripheral Arterial Disease (PAD) Therapeutics by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Peripheral Arterial Disease (PAD) Therapeutics Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Peripheral Arterial Disease (PAD) Therapeutics by Type (2025-2030)
11.1.2 Global Peripheral Arterial Disease (PAD) Therapeutics Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Peripheral Arterial Disease (PAD) Therapeutics by Type (2025-2030)
11.2 Global Peripheral Arterial Disease (PAD) Therapeutics Market Forecast by Application (2025-2030)
11.2.1 Global Peripheral Arterial Disease (PAD) Therapeutics Sales (K Units) Forecast by Application
11.2.2 Global Peripheral Arterial Disease (PAD) Therapeutics Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Peripheral Arterial Disease (PAD) Therapeutics
1.2 Key Market Segments
1.2.1 Peripheral Arterial Disease (PAD) Therapeutics Segment by Type
1.2.2 Peripheral Arterial Disease (PAD) Therapeutics Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 PERIPHERAL ARTERIAL DISEASE (PAD) THERAPEUTICS MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Peripheral Arterial Disease (PAD) Therapeutics Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Peripheral Arterial Disease (PAD) Therapeutics Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 PERIPHERAL ARTERIAL DISEASE (PAD) THERAPEUTICS MARKET COMPETITIVE LANDSCAPE
3.1 Global Peripheral Arterial Disease (PAD) Therapeutics Sales by Manufacturers (2019-2024)
3.2 Global Peripheral Arterial Disease (PAD) Therapeutics Revenue Market Share by Manufacturers (2019-2024)
3.3 Peripheral Arterial Disease (PAD) Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Peripheral Arterial Disease (PAD) Therapeutics Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Peripheral Arterial Disease (PAD) Therapeutics Sales Sites, Area Served, Product Type
3.6 Peripheral Arterial Disease (PAD) Therapeutics Market Competitive Situation and Trends
3.6.1 Peripheral Arterial Disease (PAD) Therapeutics Market Concentration Rate
3.6.2 Global 5 and 10 Largest Peripheral Arterial Disease (PAD) Therapeutics Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 PERIPHERAL ARTERIAL DISEASE (PAD) THERAPEUTICS INDUSTRY CHAIN ANALYSIS
4.1 Peripheral Arterial Disease (PAD) Therapeutics Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF PERIPHERAL ARTERIAL DISEASE (PAD) THERAPEUTICS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 PERIPHERAL ARTERIAL DISEASE (PAD) THERAPEUTICS MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Peripheral Arterial Disease (PAD) Therapeutics Sales Market Share by Type (2019-2024)
6.3 Global Peripheral Arterial Disease (PAD) Therapeutics Market Size Market Share by Type (2019-2024)
6.4 Global Peripheral Arterial Disease (PAD) Therapeutics Price by Type (2019-2024)
7 PERIPHERAL ARTERIAL DISEASE (PAD) THERAPEUTICS MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Peripheral Arterial Disease (PAD) Therapeutics Market Sales by Application (2019-2024)
7.3 Global Peripheral Arterial Disease (PAD) Therapeutics Market Size (M USD) by Application (2019-2024)
7.4 Global Peripheral Arterial Disease (PAD) Therapeutics Sales Growth Rate by Application (2019-2024)
8 PERIPHERAL ARTERIAL DISEASE (PAD) THERAPEUTICS MARKET SEGMENTATION BY REGION
8.1 Global Peripheral Arterial Disease (PAD) Therapeutics Sales by Region
8.1.1 Global Peripheral Arterial Disease (PAD) Therapeutics Sales by Region
8.1.2 Global Peripheral Arterial Disease (PAD) Therapeutics Sales Market Share by Region
8.2 North America
8.2.1 North America Peripheral Arterial Disease (PAD) Therapeutics Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Peripheral Arterial Disease (PAD) Therapeutics Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Peripheral Arterial Disease (PAD) Therapeutics Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Peripheral Arterial Disease (PAD) Therapeutics Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Peripheral Arterial Disease (PAD) Therapeutics Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 AstraZeneca Plc. (UK)
9.1.1 AstraZeneca Plc. (UK) Peripheral Arterial Disease (PAD) Therapeutics Basic Information
9.1.2 AstraZeneca Plc. (UK) Peripheral Arterial Disease (PAD) Therapeutics Product Overview
9.1.3 AstraZeneca Plc. (UK) Peripheral Arterial Disease (PAD) Therapeutics Product Market Performance
9.1.4 AstraZeneca Plc. (UK) Business Overview
9.1.5 AstraZeneca Plc. (UK) Peripheral Arterial Disease (PAD) Therapeutics SWOT Analysis
9.1.6 AstraZeneca Plc. (UK) Recent Developments
9.2 Bayer HealthCare Pharmaceuticals (Germany)
9.2.1 Bayer HealthCare Pharmaceuticals (Germany) Peripheral Arterial Disease (PAD) Therapeutics Basic Information
9.2.2 Bayer HealthCare Pharmaceuticals (Germany) Peripheral Arterial Disease (PAD) Therapeutics Product Overview
9.2.3 Bayer HealthCare Pharmaceuticals (Germany) Peripheral Arterial Disease (PAD) Therapeutics Product Market Performance
9.2.4 Bayer HealthCare Pharmaceuticals (Germany) Business Overview
9.2.5 Bayer HealthCare Pharmaceuticals (Germany) Peripheral Arterial Disease (PAD) Therapeutics SWOT Analysis
9.2.6 Bayer HealthCare Pharmaceuticals (Germany) Recent Developments
9.3 Bristol-Myers Squibb Company (US)
9.3.1 Bristol-Myers Squibb Company (US) Peripheral Arterial Disease (PAD) Therapeutics Basic Information
9.3.2 Bristol-Myers Squibb Company (US) Peripheral Arterial Disease (PAD) Therapeutics Product Overview
9.3.3 Bristol-Myers Squibb Company (US) Peripheral Arterial Disease (PAD) Therapeutics Product Market Performance
9.3.4 Bristol-Myers Squibb Company (US) Peripheral Arterial Disease (PAD) Therapeutics SWOT Analysis
9.3.5 Bristol-Myers Squibb Company (US) Business Overview
9.3.6 Bristol-Myers Squibb Company (US) Recent Developments
9.4 Merck and Co., Inc. (US)
9.4.1 Merck and Co., Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Basic Information
9.4.2 Merck and Co., Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Product Overview
9.4.3 Merck and Co., Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Product Market Performance
9.4.4 Merck and Co., Inc. (US) Business Overview
9.4.5 Merck and Co., Inc. (US) Recent Developments
9.5 Proteon Therapeutics, Inc. (US)
9.5.1 Proteon Therapeutics, Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Basic Information
9.5.2 Proteon Therapeutics, Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Product Overview
9.5.3 Proteon Therapeutics, Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Product Market Performance
9.5.4 Proteon Therapeutics, Inc. (US) Business Overview
9.5.5 Proteon Therapeutics, Inc. (US) Recent Developments
9.6 Sanofi S.A. (France)
9.6.1 Sanofi S.A. (France) Peripheral Arterial Disease (PAD) Therapeutics Basic Information
9.6.2 Sanofi S.A. (France) Peripheral Arterial Disease (PAD) Therapeutics Product Overview
9.6.3 Sanofi S.A. (France) Peripheral Arterial Disease (PAD) Therapeutics Product Market Performance
9.6.4 Sanofi S.A. (France) Business Overview
9.6.5 Sanofi S.A. (France) Recent Developments
9.7 Symic Bio, Inc. (US)
9.7.1 Symic Bio, Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Basic Information
9.7.2 Symic Bio, Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Product Overview
9.7.3 Symic Bio, Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Product Market Performance
9.7.4 Symic Bio, Inc. (US) Business Overview
9.7.5 Symic Bio, Inc. (US) Recent Developments
9.8 TheraVasc Inc. (US)
9.8.1 TheraVasc Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Basic Information
9.8.2 TheraVasc Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Product Overview
9.8.3 TheraVasc Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Product Market Performance
9.8.4 TheraVasc Inc. (US) Business Overview
9.8.5 TheraVasc Inc. (US) Recent Developments
9.9 AnGes MG, Inc. (Japan)
9.9.1 AnGes MG, Inc. (Japan) Peripheral Arterial Disease (PAD) Therapeutics Basic Information
9.9.2 AnGes MG, Inc. (Japan) Peripheral Arterial Disease (PAD) Therapeutics Product Overview
9.9.3 AnGes MG, Inc. (Japan) Peripheral Arterial Disease (PAD) Therapeutics Product Market Performance
9.9.4 AnGes MG, Inc. (Japan) Business Overview
9.9.5 AnGes MG, Inc. (Japan) Recent Developments
9.10 Athersys, Inc. (US)
9.10.1 Athersys, Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Basic Information
9.10.2 Athersys, Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Product Overview
9.10.3 Athersys, Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Product Market Performance
9.10.4 Athersys, Inc. (US) Business Overview
9.10.5 Athersys, Inc. (US) Recent Developments
9.11 Betagenon AB (Sweden)
9.11.1 Betagenon AB (Sweden) Peripheral Arterial Disease (PAD) Therapeutics Basic Information
9.11.2 Betagenon AB (Sweden) Peripheral Arterial Disease (PAD) Therapeutics Product Overview
9.11.3 Betagenon AB (Sweden) Peripheral Arterial Disease (PAD) Therapeutics Product Market Performance
9.11.4 Betagenon AB (Sweden) Business Overview
9.11.5 Betagenon AB (Sweden) Recent Developments
9.12 miRagen Therapeutics, Inc. (US)
9.12.1 miRagen Therapeutics, Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Basic Information
9.12.2 miRagen Therapeutics, Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Product Overview
9.12.3 miRagen Therapeutics, Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Product Market Performance
9.12.4 miRagen Therapeutics, Inc. (US) Business Overview
9.12.5 miRagen Therapeutics, Inc. (US) Recent Developments
9.13 Multi Gene Vascular Systems Ltd (Israel)
9.13.1 Multi Gene Vascular Systems Ltd (Israel) Peripheral Arterial Disease (PAD) Therapeutics Basic Information
9.13.2 Multi Gene Vascular Systems Ltd (Israel) Peripheral Arterial Disease (PAD) Therapeutics Product Overview
9.13.3 Multi Gene Vascular Systems Ltd (Israel) Peripheral Arterial Disease (PAD) Therapeutics Product Market Performance
9.13.4 Multi Gene Vascular Systems Ltd (Israel) Business Overview
9.13.5 Multi Gene Vascular Systems Ltd (Israel) Recent Developments
9.14 ViroMed Co. Ltd. (Korea)
9.14.1 ViroMed Co. Ltd. (Korea) Peripheral Arterial Disease (PAD) Therapeutics Basic Information
9.14.2 ViroMed Co. Ltd. (Korea) Peripheral Arterial Disease (PAD) Therapeutics Product Overview
9.14.3 ViroMed Co. Ltd. (Korea) Peripheral Arterial Disease (PAD) Therapeutics Product Market Performance
9.14.4 ViroMed Co. Ltd. (Korea) Business Overview
9.14.5 ViroMed Co. Ltd. (Korea) Recent Developments
10 PERIPHERAL ARTERIAL DISEASE (PAD) THERAPEUTICS MARKET FORECAST BY REGION
10.1 Global Peripheral Arterial Disease (PAD) Therapeutics Market Size Forecast
10.2 Global Peripheral Arterial Disease (PAD) Therapeutics Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Peripheral Arterial Disease (PAD) Therapeutics Market Size Forecast by Country
10.2.3 Asia Pacific Peripheral Arterial Disease (PAD) Therapeutics Market Size Forecast by Region
10.2.4 South America Peripheral Arterial Disease (PAD) Therapeutics Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Peripheral Arterial Disease (PAD) Therapeutics by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Peripheral Arterial Disease (PAD) Therapeutics Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Peripheral Arterial Disease (PAD) Therapeutics by Type (2025-2030)
11.1.2 Global Peripheral Arterial Disease (PAD) Therapeutics Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Peripheral Arterial Disease (PAD) Therapeutics by Type (2025-2030)
11.2 Global Peripheral Arterial Disease (PAD) Therapeutics Market Forecast by Application (2025-2030)
11.2.1 Global Peripheral Arterial Disease (PAD) Therapeutics Sales (K Units) Forecast by Application
11.2.2 Global Peripheral Arterial Disease (PAD) Therapeutics Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Peripheral Arterial Disease (PAD) Therapeutics Market Size Comparison by Region (M USD)
Table 5. Global Peripheral Arterial Disease (PAD) Therapeutics Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global Peripheral Arterial Disease (PAD) Therapeutics Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Peripheral Arterial Disease (PAD) Therapeutics Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Peripheral Arterial Disease (PAD) Therapeutics Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Peripheral Arterial Disease (PAD) Therapeutics as of 2022)
Table 10. Global Market Peripheral Arterial Disease (PAD) Therapeutics Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Peripheral Arterial Disease (PAD) Therapeutics Sales Sites and Area Served
Table 12. Manufacturers Peripheral Arterial Disease (PAD) Therapeutics Product Type
Table 13. Global Peripheral Arterial Disease (PAD) Therapeutics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Peripheral Arterial Disease (PAD) Therapeutics
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Peripheral Arterial Disease (PAD) Therapeutics Market Challenges
Table 22. Global Peripheral Arterial Disease (PAD) Therapeutics Sales by Type (K Units)
Table 23. Global Peripheral Arterial Disease (PAD) Therapeutics Market Size by Type (M USD)
Table 24. Global Peripheral Arterial Disease (PAD) Therapeutics Sales (K Units) by Type (2019-2024)
Table 25. Global Peripheral Arterial Disease (PAD) Therapeutics Sales Market Share by Type (2019-2024)
Table 26. Global Peripheral Arterial Disease (PAD) Therapeutics Market Size (M USD) by Type (2019-2024)
Table 27. Global Peripheral Arterial Disease (PAD) Therapeutics Market Size Share by Type (2019-2024)
Table 28. Global Peripheral Arterial Disease (PAD) Therapeutics Price (USD/Unit) by Type (2019-2024)
Table 29. Global Peripheral Arterial Disease (PAD) Therapeutics Sales (K Units) by Application
Table 30. Global Peripheral Arterial Disease (PAD) Therapeutics Market Size by Application
Table 31. Global Peripheral Arterial Disease (PAD) Therapeutics Sales by Application (2019-2024) & (K Units)
Table 32. Global Peripheral Arterial Disease (PAD) Therapeutics Sales Market Share by Application (2019-2024)
Table 33. Global Peripheral Arterial Disease (PAD) Therapeutics Sales by Application (2019-2024) & (M USD)
Table 34. Global Peripheral Arterial Disease (PAD) Therapeutics Market Share by Application (2019-2024)
Table 35. Global Peripheral Arterial Disease (PAD) Therapeutics Sales Growth Rate by Application (2019-2024)
Table 36. Global Peripheral Arterial Disease (PAD) Therapeutics Sales by Region (2019-2024) & (K Units)
Table 37. Global Peripheral Arterial Disease (PAD) Therapeutics Sales Market Share by Region (2019-2024)
Table 38. North America Peripheral Arterial Disease (PAD) Therapeutics Sales by Country (2019-2024) & (K Units)
Table 39. Europe Peripheral Arterial Disease (PAD) Therapeutics Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific Peripheral Arterial Disease (PAD) Therapeutics Sales by Region (2019-2024) & (K Units)
Table 41. South America Peripheral Arterial Disease (PAD) Therapeutics Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa Peripheral Arterial Disease (PAD) Therapeutics Sales by Region (2019-2024) & (K Units)
Table 43. AstraZeneca Plc. (UK) Peripheral Arterial Disease (PAD) Therapeutics Basic Information
Table 44. AstraZeneca Plc. (UK) Peripheral Arterial Disease (PAD) Therapeutics Product Overview
Table 45. AstraZeneca Plc. (UK) Peripheral Arterial Disease (PAD) Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 46. AstraZeneca Plc. (UK) Business Overview
Table 47. AstraZeneca Plc. (UK) Peripheral Arterial Disease (PAD) Therapeutics SWOT Analysis
Table 48. AstraZeneca Plc. (UK) Recent Developments
Table 49. Bayer HealthCare Pharmaceuticals (Germany) Peripheral Arterial Disease (PAD) Therapeutics Basic Information
Table 50. Bayer HealthCare Pharmaceuticals (Germany) Peripheral Arterial Disease (PAD) Therapeutics Product Overview
Table 51. Bayer HealthCare Pharmaceuticals (Germany) Peripheral Arterial Disease (PAD) Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 52. Bayer HealthCare Pharmaceuticals (Germany) Business Overview
Table 53. Bayer HealthCare Pharmaceuticals (Germany) Peripheral Arterial Disease (PAD) Therapeutics SWOT Analysis
Table 54. Bayer HealthCare Pharmaceuticals (Germany) Recent Developments
Table 55. Bristol-Myers Squibb Company (US) Peripheral Arterial Disease (PAD) Therapeutics Basic Information
Table 56. Bristol-Myers Squibb Company (US) Peripheral Arterial Disease (PAD) Therapeutics Product Overview
Table 57. Bristol-Myers Squibb Company (US) Peripheral Arterial Disease (PAD) Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 58. Bristol-Myers Squibb Company (US) Peripheral Arterial Disease (PAD) Therapeutics SWOT Analysis
Table 59. Bristol-Myers Squibb Company (US) Business Overview
Table 60. Bristol-Myers Squibb Company (US) Recent Developments
Table 61. Merck and Co., Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Basic Information
Table 62. Merck and Co., Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Product Overview
Table 63. Merck and Co., Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 64. Merck and Co., Inc. (US) Business Overview
Table 65. Merck and Co., Inc. (US) Recent Developments
Table 66. Proteon Therapeutics, Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Basic Information
Table 67. Proteon Therapeutics, Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Product Overview
Table 68. Proteon Therapeutics, Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 69. Proteon Therapeutics, Inc. (US) Business Overview
Table 70. Proteon Therapeutics, Inc. (US) Recent Developments
Table 71. Sanofi S.A. (France) Peripheral Arterial Disease (PAD) Therapeutics Basic Information
Table 72. Sanofi S.A. (France) Peripheral Arterial Disease (PAD) Therapeutics Product Overview
Table 73. Sanofi S.A. (France) Peripheral Arterial Disease (PAD) Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 74. Sanofi S.A. (France) Business Overview
Table 75. Sanofi S.A. (France) Recent Developments
Table 76. Symic Bio, Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Basic Information
Table 77. Symic Bio, Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Product Overview
Table 78. Symic Bio, Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 79. Symic Bio, Inc. (US) Business Overview
Table 80. Symic Bio, Inc. (US) Recent Developments
Table 81. TheraVasc Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Basic Information
Table 82. TheraVasc Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Product Overview
Table 83. TheraVasc Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 84. TheraVasc Inc. (US) Business Overview
Table 85. TheraVasc Inc. (US) Recent Developments
Table 86. AnGes MG, Inc. (Japan) Peripheral Arterial Disease (PAD) Therapeutics Basic Information
Table 87. AnGes MG, Inc. (Japan) Peripheral Arterial Disease (PAD) Therapeutics Product Overview
Table 88. AnGes MG, Inc. (Japan) Peripheral Arterial Disease (PAD) Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 89. AnGes MG, Inc. (Japan) Business Overview
Table 90. AnGes MG, Inc. (Japan) Recent Developments
Table 91. Athersys, Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Basic Information
Table 92. Athersys, Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Product Overview
Table 93. Athersys, Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 94. Athersys, Inc. (US) Business Overview
Table 95. Athersys, Inc. (US) Recent Developments
Table 96. Betagenon AB (Sweden) Peripheral Arterial Disease (PAD) Therapeutics Basic Information
Table 97. Betagenon AB (Sweden) Peripheral Arterial Disease (PAD) Therapeutics Product Overview
Table 98. Betagenon AB (Sweden) Peripheral Arterial Disease (PAD) Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 99. Betagenon AB (Sweden) Business Overview
Table 100. Betagenon AB (Sweden) Recent Developments
Table 101. miRagen Therapeutics, Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Basic Information
Table 102. miRagen Therapeutics, Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Product Overview
Table 103. miRagen Therapeutics, Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 104. miRagen Therapeutics, Inc. (US) Business Overview
Table 105. miRagen Therapeutics, Inc. (US) Recent Developments
Table 106. Multi Gene Vascular Systems Ltd (Israel) Peripheral Arterial Disease (PAD) Therapeutics Basic Information
Table 107. Multi Gene Vascular Systems Ltd (Israel) Peripheral Arterial Disease (PAD) Therapeutics Product Overview
Table 108. Multi Gene Vascular Systems Ltd (Israel) Peripheral Arterial Disease (PAD) Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 109. Multi Gene Vascular Systems Ltd (Israel) Business Overview
Table 110. Multi Gene Vascular Systems Ltd (Israel) Recent Developments
Table 111. ViroMed Co. Ltd. (Korea) Peripheral Arterial Disease (PAD) Therapeutics Basic Information
Table 112. ViroMed Co. Ltd. (Korea) Peripheral Arterial Disease (PAD) Therapeutics Product Overview
Table 113. ViroMed Co. Ltd. (Korea) Peripheral Arterial Disease (PAD) Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 114. ViroMed Co. Ltd. (Korea) Business Overview
Table 115. ViroMed Co. Ltd. (Korea) Recent Developments
Table 116. Global Peripheral Arterial Disease (PAD) Therapeutics Sales Forecast by Region (2025-2030) & (K Units)
Table 117. Global Peripheral Arterial Disease (PAD) Therapeutics Market Size Forecast by Region (2025-2030) & (M USD)
Table 118. North America Peripheral Arterial Disease (PAD) Therapeutics Sales Forecast by Country (2025-2030) & (K Units)
Table 119. North America Peripheral Arterial Disease (PAD) Therapeutics Market Size Forecast by Country (2025-2030) & (M USD)
Table 120. Europe Peripheral Arterial Disease (PAD) Therapeutics Sales Forecast by Country (2025-2030) & (K Units)
Table 121. Europe Peripheral Arterial Disease (PAD) Therapeutics Market Size Forecast by Country (2025-2030) & (M USD)
Table 122. Asia Pacific Peripheral Arterial Disease (PAD) Therapeutics Sales Forecast by Region (2025-2030) & (K Units)
Table 123. Asia Pacific Peripheral Arterial Disease (PAD) Therapeutics Market Size Forecast by Region (2025-2030) & (M USD)
Table 124. South America Peripheral Arterial Disease (PAD) Therapeutics Sales Forecast by Country (2025-2030) & (K Units)
Table 125. South America Peripheral Arterial Disease (PAD) Therapeutics Market Size Forecast by Country (2025-2030) & (M USD)
Table 126. Middle East and Africa Peripheral Arterial Disease (PAD) Therapeutics Consumption Forecast by Country (2025-2030) & (Units)
Table 127. Middle East and Africa Peripheral Arterial Disease (PAD) Therapeutics Market Size Forecast by Country (2025-2030) & (M USD)
Table 128. Global Peripheral Arterial Disease (PAD) Therapeutics Sales Forecast by Type (2025-2030) & (K Units)
Table 129. Global Peripheral Arterial Disease (PAD) Therapeutics Market Size Forecast by Type (2025-2030) & (M USD)
Table 130. Global Peripheral Arterial Disease (PAD) Therapeutics Price Forecast by Type (2025-2030) & (USD/Unit)
Table 131. Global Peripheral Arterial Disease (PAD) Therapeutics Sales (K Units) Forecast by Application (2025-2030)
Table 132. Global Peripheral Arterial Disease (PAD) Therapeutics Market Size Forecast by Application (2025-2030) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Peripheral Arterial Disease (PAD) Therapeutics Market Size Comparison by Region (M USD)
Table 5. Global Peripheral Arterial Disease (PAD) Therapeutics Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global Peripheral Arterial Disease (PAD) Therapeutics Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Peripheral Arterial Disease (PAD) Therapeutics Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Peripheral Arterial Disease (PAD) Therapeutics Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Peripheral Arterial Disease (PAD) Therapeutics as of 2022)
Table 10. Global Market Peripheral Arterial Disease (PAD) Therapeutics Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Peripheral Arterial Disease (PAD) Therapeutics Sales Sites and Area Served
Table 12. Manufacturers Peripheral Arterial Disease (PAD) Therapeutics Product Type
Table 13. Global Peripheral Arterial Disease (PAD) Therapeutics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Peripheral Arterial Disease (PAD) Therapeutics
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Peripheral Arterial Disease (PAD) Therapeutics Market Challenges
Table 22. Global Peripheral Arterial Disease (PAD) Therapeutics Sales by Type (K Units)
Table 23. Global Peripheral Arterial Disease (PAD) Therapeutics Market Size by Type (M USD)
Table 24. Global Peripheral Arterial Disease (PAD) Therapeutics Sales (K Units) by Type (2019-2024)
Table 25. Global Peripheral Arterial Disease (PAD) Therapeutics Sales Market Share by Type (2019-2024)
Table 26. Global Peripheral Arterial Disease (PAD) Therapeutics Market Size (M USD) by Type (2019-2024)
Table 27. Global Peripheral Arterial Disease (PAD) Therapeutics Market Size Share by Type (2019-2024)
Table 28. Global Peripheral Arterial Disease (PAD) Therapeutics Price (USD/Unit) by Type (2019-2024)
Table 29. Global Peripheral Arterial Disease (PAD) Therapeutics Sales (K Units) by Application
Table 30. Global Peripheral Arterial Disease (PAD) Therapeutics Market Size by Application
Table 31. Global Peripheral Arterial Disease (PAD) Therapeutics Sales by Application (2019-2024) & (K Units)
Table 32. Global Peripheral Arterial Disease (PAD) Therapeutics Sales Market Share by Application (2019-2024)
Table 33. Global Peripheral Arterial Disease (PAD) Therapeutics Sales by Application (2019-2024) & (M USD)
Table 34. Global Peripheral Arterial Disease (PAD) Therapeutics Market Share by Application (2019-2024)
Table 35. Global Peripheral Arterial Disease (PAD) Therapeutics Sales Growth Rate by Application (2019-2024)
Table 36. Global Peripheral Arterial Disease (PAD) Therapeutics Sales by Region (2019-2024) & (K Units)
Table 37. Global Peripheral Arterial Disease (PAD) Therapeutics Sales Market Share by Region (2019-2024)
Table 38. North America Peripheral Arterial Disease (PAD) Therapeutics Sales by Country (2019-2024) & (K Units)
Table 39. Europe Peripheral Arterial Disease (PAD) Therapeutics Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific Peripheral Arterial Disease (PAD) Therapeutics Sales by Region (2019-2024) & (K Units)
Table 41. South America Peripheral Arterial Disease (PAD) Therapeutics Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa Peripheral Arterial Disease (PAD) Therapeutics Sales by Region (2019-2024) & (K Units)
Table 43. AstraZeneca Plc. (UK) Peripheral Arterial Disease (PAD) Therapeutics Basic Information
Table 44. AstraZeneca Plc. (UK) Peripheral Arterial Disease (PAD) Therapeutics Product Overview
Table 45. AstraZeneca Plc. (UK) Peripheral Arterial Disease (PAD) Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 46. AstraZeneca Plc. (UK) Business Overview
Table 47. AstraZeneca Plc. (UK) Peripheral Arterial Disease (PAD) Therapeutics SWOT Analysis
Table 48. AstraZeneca Plc. (UK) Recent Developments
Table 49. Bayer HealthCare Pharmaceuticals (Germany) Peripheral Arterial Disease (PAD) Therapeutics Basic Information
Table 50. Bayer HealthCare Pharmaceuticals (Germany) Peripheral Arterial Disease (PAD) Therapeutics Product Overview
Table 51. Bayer HealthCare Pharmaceuticals (Germany) Peripheral Arterial Disease (PAD) Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 52. Bayer HealthCare Pharmaceuticals (Germany) Business Overview
Table 53. Bayer HealthCare Pharmaceuticals (Germany) Peripheral Arterial Disease (PAD) Therapeutics SWOT Analysis
Table 54. Bayer HealthCare Pharmaceuticals (Germany) Recent Developments
Table 55. Bristol-Myers Squibb Company (US) Peripheral Arterial Disease (PAD) Therapeutics Basic Information
Table 56. Bristol-Myers Squibb Company (US) Peripheral Arterial Disease (PAD) Therapeutics Product Overview
Table 57. Bristol-Myers Squibb Company (US) Peripheral Arterial Disease (PAD) Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 58. Bristol-Myers Squibb Company (US) Peripheral Arterial Disease (PAD) Therapeutics SWOT Analysis
Table 59. Bristol-Myers Squibb Company (US) Business Overview
Table 60. Bristol-Myers Squibb Company (US) Recent Developments
Table 61. Merck and Co., Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Basic Information
Table 62. Merck and Co., Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Product Overview
Table 63. Merck and Co., Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 64. Merck and Co., Inc. (US) Business Overview
Table 65. Merck and Co., Inc. (US) Recent Developments
Table 66. Proteon Therapeutics, Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Basic Information
Table 67. Proteon Therapeutics, Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Product Overview
Table 68. Proteon Therapeutics, Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 69. Proteon Therapeutics, Inc. (US) Business Overview
Table 70. Proteon Therapeutics, Inc. (US) Recent Developments
Table 71. Sanofi S.A. (France) Peripheral Arterial Disease (PAD) Therapeutics Basic Information
Table 72. Sanofi S.A. (France) Peripheral Arterial Disease (PAD) Therapeutics Product Overview
Table 73. Sanofi S.A. (France) Peripheral Arterial Disease (PAD) Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 74. Sanofi S.A. (France) Business Overview
Table 75. Sanofi S.A. (France) Recent Developments
Table 76. Symic Bio, Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Basic Information
Table 77. Symic Bio, Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Product Overview
Table 78. Symic Bio, Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 79. Symic Bio, Inc. (US) Business Overview
Table 80. Symic Bio, Inc. (US) Recent Developments
Table 81. TheraVasc Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Basic Information
Table 82. TheraVasc Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Product Overview
Table 83. TheraVasc Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 84. TheraVasc Inc. (US) Business Overview
Table 85. TheraVasc Inc. (US) Recent Developments
Table 86. AnGes MG, Inc. (Japan) Peripheral Arterial Disease (PAD) Therapeutics Basic Information
Table 87. AnGes MG, Inc. (Japan) Peripheral Arterial Disease (PAD) Therapeutics Product Overview
Table 88. AnGes MG, Inc. (Japan) Peripheral Arterial Disease (PAD) Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 89. AnGes MG, Inc. (Japan) Business Overview
Table 90. AnGes MG, Inc. (Japan) Recent Developments
Table 91. Athersys, Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Basic Information
Table 92. Athersys, Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Product Overview
Table 93. Athersys, Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 94. Athersys, Inc. (US) Business Overview
Table 95. Athersys, Inc. (US) Recent Developments
Table 96. Betagenon AB (Sweden) Peripheral Arterial Disease (PAD) Therapeutics Basic Information
Table 97. Betagenon AB (Sweden) Peripheral Arterial Disease (PAD) Therapeutics Product Overview
Table 98. Betagenon AB (Sweden) Peripheral Arterial Disease (PAD) Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 99. Betagenon AB (Sweden) Business Overview
Table 100. Betagenon AB (Sweden) Recent Developments
Table 101. miRagen Therapeutics, Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Basic Information
Table 102. miRagen Therapeutics, Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Product Overview
Table 103. miRagen Therapeutics, Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 104. miRagen Therapeutics, Inc. (US) Business Overview
Table 105. miRagen Therapeutics, Inc. (US) Recent Developments
Table 106. Multi Gene Vascular Systems Ltd (Israel) Peripheral Arterial Disease (PAD) Therapeutics Basic Information
Table 107. Multi Gene Vascular Systems Ltd (Israel) Peripheral Arterial Disease (PAD) Therapeutics Product Overview
Table 108. Multi Gene Vascular Systems Ltd (Israel) Peripheral Arterial Disease (PAD) Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 109. Multi Gene Vascular Systems Ltd (Israel) Business Overview
Table 110. Multi Gene Vascular Systems Ltd (Israel) Recent Developments
Table 111. ViroMed Co. Ltd. (Korea) Peripheral Arterial Disease (PAD) Therapeutics Basic Information
Table 112. ViroMed Co. Ltd. (Korea) Peripheral Arterial Disease (PAD) Therapeutics Product Overview
Table 113. ViroMed Co. Ltd. (Korea) Peripheral Arterial Disease (PAD) Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 114. ViroMed Co. Ltd. (Korea) Business Overview
Table 115. ViroMed Co. Ltd. (Korea) Recent Developments
Table 116. Global Peripheral Arterial Disease (PAD) Therapeutics Sales Forecast by Region (2025-2030) & (K Units)
Table 117. Global Peripheral Arterial Disease (PAD) Therapeutics Market Size Forecast by Region (2025-2030) & (M USD)
Table 118. North America Peripheral Arterial Disease (PAD) Therapeutics Sales Forecast by Country (2025-2030) & (K Units)
Table 119. North America Peripheral Arterial Disease (PAD) Therapeutics Market Size Forecast by Country (2025-2030) & (M USD)
Table 120. Europe Peripheral Arterial Disease (PAD) Therapeutics Sales Forecast by Country (2025-2030) & (K Units)
Table 121. Europe Peripheral Arterial Disease (PAD) Therapeutics Market Size Forecast by Country (2025-2030) & (M USD)
Table 122. Asia Pacific Peripheral Arterial Disease (PAD) Therapeutics Sales Forecast by Region (2025-2030) & (K Units)
Table 123. Asia Pacific Peripheral Arterial Disease (PAD) Therapeutics Market Size Forecast by Region (2025-2030) & (M USD)
Table 124. South America Peripheral Arterial Disease (PAD) Therapeutics Sales Forecast by Country (2025-2030) & (K Units)
Table 125. South America Peripheral Arterial Disease (PAD) Therapeutics Market Size Forecast by Country (2025-2030) & (M USD)
Table 126. Middle East and Africa Peripheral Arterial Disease (PAD) Therapeutics Consumption Forecast by Country (2025-2030) & (Units)
Table 127. Middle East and Africa Peripheral Arterial Disease (PAD) Therapeutics Market Size Forecast by Country (2025-2030) & (M USD)
Table 128. Global Peripheral Arterial Disease (PAD) Therapeutics Sales Forecast by Type (2025-2030) & (K Units)
Table 129. Global Peripheral Arterial Disease (PAD) Therapeutics Market Size Forecast by Type (2025-2030) & (M USD)
Table 130. Global Peripheral Arterial Disease (PAD) Therapeutics Price Forecast by Type (2025-2030) & (USD/Unit)
Table 131. Global Peripheral Arterial Disease (PAD) Therapeutics Sales (K Units) Forecast by Application (2025-2030)
Table 132. Global Peripheral Arterial Disease (PAD) Therapeutics Market Size Forecast by Application (2025-2030) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Peripheral Arterial Disease (PAD) Therapeutics
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Peripheral Arterial Disease (PAD) Therapeutics Market Size (M USD), 2019-2030
Figure 5. Global Peripheral Arterial Disease (PAD) Therapeutics Market Size (M USD) (2019-2030)
Figure 6. Global Peripheral Arterial Disease (PAD) Therapeutics Sales (K Units) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Peripheral Arterial Disease (PAD) Therapeutics Market Size by Country (M USD)
Figure 11. Peripheral Arterial Disease (PAD) Therapeutics Sales Share by Manufacturers in 2023
Figure 12. Global Peripheral Arterial Disease (PAD) Therapeutics Revenue Share by Manufacturers in 2023
Figure 13. Peripheral Arterial Disease (PAD) Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Peripheral Arterial Disease (PAD) Therapeutics Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Peripheral Arterial Disease (PAD) Therapeutics Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Peripheral Arterial Disease (PAD) Therapeutics Market Share by Type
Figure 18. Sales Market Share of Peripheral Arterial Disease (PAD) Therapeutics by Type (2019-2024)
Figure 19. Sales Market Share of Peripheral Arterial Disease (PAD) Therapeutics by Type in 2023
Figure 20. Market Size Share of Peripheral Arterial Disease (PAD) Therapeutics by Type (2019-2024)
Figure 21. Market Size Market Share of Peripheral Arterial Disease (PAD) Therapeutics by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Peripheral Arterial Disease (PAD) Therapeutics Market Share by Application
Figure 24. Global Peripheral Arterial Disease (PAD) Therapeutics Sales Market Share by Application (2019-2024)
Figure 25. Global Peripheral Arterial Disease (PAD) Therapeutics Sales Market Share by Application in 2023
Figure 26. Global Peripheral Arterial Disease (PAD) Therapeutics Market Share by Application (2019-2024)
Figure 27. Global Peripheral Arterial Disease (PAD) Therapeutics Market Share by Application in 2023
Figure 28. Global Peripheral Arterial Disease (PAD) Therapeutics Sales Growth Rate by Application (2019-2024)
Figure 29. Global Peripheral Arterial Disease (PAD) Therapeutics Sales Market Share by Region (2019-2024)
Figure 30. North America Peripheral Arterial Disease (PAD) Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America Peripheral Arterial Disease (PAD) Therapeutics Sales Market Share by Country in 2023
Figure 32. U.S. Peripheral Arterial Disease (PAD) Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada Peripheral Arterial Disease (PAD) Therapeutics Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico Peripheral Arterial Disease (PAD) Therapeutics Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Peripheral Arterial Disease (PAD) Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe Peripheral Arterial Disease (PAD) Therapeutics Sales Market Share by Country in 2023
Figure 37. Germany Peripheral Arterial Disease (PAD) Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France Peripheral Arterial Disease (PAD) Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. Peripheral Arterial Disease (PAD) Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy Peripheral Arterial Disease (PAD) Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia Peripheral Arterial Disease (PAD) Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific Peripheral Arterial Disease (PAD) Therapeutics Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Peripheral Arterial Disease (PAD) Therapeutics Sales Market Share by Region in 2023
Figure 44. China Peripheral Arterial Disease (PAD) Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan Peripheral Arterial Disease (PAD) Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea Peripheral Arterial Disease (PAD) Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India Peripheral Arterial Disease (PAD) Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia Peripheral Arterial Disease (PAD) Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America Peripheral Arterial Disease (PAD) Therapeutics Sales and Growth Rate (K Units)
Figure 50. South America Peripheral Arterial Disease (PAD) Therapeutics Sales Market Share by Country in 2023
Figure 51. Brazil Peripheral Arterial Disease (PAD) Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina Peripheral Arterial Disease (PAD) Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia Peripheral Arterial Disease (PAD) Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa Peripheral Arterial Disease (PAD) Therapeutics Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Peripheral Arterial Disease (PAD) Therapeutics Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Peripheral Arterial Disease (PAD) Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE Peripheral Arterial Disease (PAD) Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt Peripheral Arterial Disease (PAD) Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria Peripheral Arterial Disease (PAD) Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa Peripheral Arterial Disease (PAD) Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global Peripheral Arterial Disease (PAD) Therapeutics Sales Forecast by Volume (2019-2030) & (K Units)
Figure 62. Global Peripheral Arterial Disease (PAD) Therapeutics Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Peripheral Arterial Disease (PAD) Therapeutics Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Peripheral Arterial Disease (PAD) Therapeutics Market Share Forecast by Type (2025-2030)
Figure 65. Global Peripheral Arterial Disease (PAD) Therapeutics Sales Forecast by Application (2025-2030)
Figure 66. Global Peripheral Arterial Disease (PAD) Therapeutics Market Share Forecast by Application (2025-2030)
Figure 1. Product Picture of Peripheral Arterial Disease (PAD) Therapeutics
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Peripheral Arterial Disease (PAD) Therapeutics Market Size (M USD), 2019-2030
Figure 5. Global Peripheral Arterial Disease (PAD) Therapeutics Market Size (M USD) (2019-2030)
Figure 6. Global Peripheral Arterial Disease (PAD) Therapeutics Sales (K Units) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Peripheral Arterial Disease (PAD) Therapeutics Market Size by Country (M USD)
Figure 11. Peripheral Arterial Disease (PAD) Therapeutics Sales Share by Manufacturers in 2023
Figure 12. Global Peripheral Arterial Disease (PAD) Therapeutics Revenue Share by Manufacturers in 2023
Figure 13. Peripheral Arterial Disease (PAD) Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Peripheral Arterial Disease (PAD) Therapeutics Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Peripheral Arterial Disease (PAD) Therapeutics Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Peripheral Arterial Disease (PAD) Therapeutics Market Share by Type
Figure 18. Sales Market Share of Peripheral Arterial Disease (PAD) Therapeutics by Type (2019-2024)
Figure 19. Sales Market Share of Peripheral Arterial Disease (PAD) Therapeutics by Type in 2023
Figure 20. Market Size Share of Peripheral Arterial Disease (PAD) Therapeutics by Type (2019-2024)
Figure 21. Market Size Market Share of Peripheral Arterial Disease (PAD) Therapeutics by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Peripheral Arterial Disease (PAD) Therapeutics Market Share by Application
Figure 24. Global Peripheral Arterial Disease (PAD) Therapeutics Sales Market Share by Application (2019-2024)
Figure 25. Global Peripheral Arterial Disease (PAD) Therapeutics Sales Market Share by Application in 2023
Figure 26. Global Peripheral Arterial Disease (PAD) Therapeutics Market Share by Application (2019-2024)
Figure 27. Global Peripheral Arterial Disease (PAD) Therapeutics Market Share by Application in 2023
Figure 28. Global Peripheral Arterial Disease (PAD) Therapeutics Sales Growth Rate by Application (2019-2024)
Figure 29. Global Peripheral Arterial Disease (PAD) Therapeutics Sales Market Share by Region (2019-2024)
Figure 30. North America Peripheral Arterial Disease (PAD) Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America Peripheral Arterial Disease (PAD) Therapeutics Sales Market Share by Country in 2023
Figure 32. U.S. Peripheral Arterial Disease (PAD) Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada Peripheral Arterial Disease (PAD) Therapeutics Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico Peripheral Arterial Disease (PAD) Therapeutics Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Peripheral Arterial Disease (PAD) Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe Peripheral Arterial Disease (PAD) Therapeutics Sales Market Share by Country in 2023
Figure 37. Germany Peripheral Arterial Disease (PAD) Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France Peripheral Arterial Disease (PAD) Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. Peripheral Arterial Disease (PAD) Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy Peripheral Arterial Disease (PAD) Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia Peripheral Arterial Disease (PAD) Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific Peripheral Arterial Disease (PAD) Therapeutics Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Peripheral Arterial Disease (PAD) Therapeutics Sales Market Share by Region in 2023
Figure 44. China Peripheral Arterial Disease (PAD) Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan Peripheral Arterial Disease (PAD) Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea Peripheral Arterial Disease (PAD) Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India Peripheral Arterial Disease (PAD) Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia Peripheral Arterial Disease (PAD) Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America Peripheral Arterial Disease (PAD) Therapeutics Sales and Growth Rate (K Units)
Figure 50. South America Peripheral Arterial Disease (PAD) Therapeutics Sales Market Share by Country in 2023
Figure 51. Brazil Peripheral Arterial Disease (PAD) Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina Peripheral Arterial Disease (PAD) Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia Peripheral Arterial Disease (PAD) Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa Peripheral Arterial Disease (PAD) Therapeutics Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Peripheral Arterial Disease (PAD) Therapeutics Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Peripheral Arterial Disease (PAD) Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE Peripheral Arterial Disease (PAD) Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt Peripheral Arterial Disease (PAD) Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria Peripheral Arterial Disease (PAD) Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa Peripheral Arterial Disease (PAD) Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global Peripheral Arterial Disease (PAD) Therapeutics Sales Forecast by Volume (2019-2030) & (K Units)
Figure 62. Global Peripheral Arterial Disease (PAD) Therapeutics Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Peripheral Arterial Disease (PAD) Therapeutics Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Peripheral Arterial Disease (PAD) Therapeutics Market Share Forecast by Type (2025-2030)
Figure 65. Global Peripheral Arterial Disease (PAD) Therapeutics Sales Forecast by Application (2025-2030)
Figure 66. Global Peripheral Arterial Disease (PAD) Therapeutics Market Share Forecast by Application (2025-2030)
